Cardiovascular Systems, Inc. (CSII): Price and Financial Metrics
CSII Price/Volume Stats
| Current price | $20.00 | 52-week high | $20.57 |
| Prev. close | $19.97 | 52-week low | $12.26 |
| Day low | $19.98 | Volume | 398,300 |
| Day high | $20.00 | Avg. volume | 765,906 |
| 50-day MA | $19.82 | Dividend yield | N/A |
| 200-day MA | $15.77 | Market Cap | 843.96M |
CSII Stock Price Chart Interactive Chart >
Cardiovascular Systems, Inc. (CSII) Company Bio
Cardiovascular Systems develops, manufactures, and markets devices for the treatment of vascular diseases, targeting a range of plaque types in leg arteries above and below the knee. The company was founded in 1989 and is based in St. Paul, Minnesota.
Latest CSII News From Around the Web
Below are the latest news stories about CARDIOVASCULAR SYSTEMS INC that investors may wish to consider to help them evaluate CSII as an investment opportunity.
Cytek Biosciences Set to Join S&P SmallCap 600Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, May 1. S&P 500 and 100 constituent Abbott Laboratories (NYSE:ABT) is acquiring Cardiovascular Systems in a deal expected to be completed soon, pending final closing conditions. |
Cardiovascular Systems, Inc.'s (NASDAQ:CSII) Subdued P/S Might Signal An OpportunityIt's not a stretch to say that Cardiovascular Systems, Inc.'s ( NASDAQ:CSII ) price-to-sales (or "P/S") ratio of 3.5x... |
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial EnrollmentCardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries. |
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical TrialST. PAUL, Minn., April 03, 2023--CARDIOVASCULAR SYSTEMS, INC. COMPLETES ENROLLMENT OF ECLIPSE CLINICAL TRIAL |
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
CSII Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 43.06% |
| 3-year | -42.35% |
| 5-year | -35.21% |
| YTD | 46.84% |
| 2022 | -27.48% |
| 2021 | -57.08% |
| 2020 | -9.94% |
| 2019 | 70.55% |
| 2018 | 20.26% |
Continue Researching CSII
Want to do more research on Cardiovascular Systems Inc's stock and its price? Try the links below:Cardiovascular Systems Inc (CSII) Stock Price | Nasdaq
Cardiovascular Systems Inc (CSII) Stock Quote, History and News - Yahoo Finance
Cardiovascular Systems Inc (CSII) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...